Early discharge for low-risk pediatric febrile neutropenia: safe only in selected centers.

Abstract

Marathe et al. report encouraging results from a step-down pathway for low-risk fever and neutropenia in pediatric and adolescent-young adult oncology patients, with reduced hospitalization and no sepsis or infection-related mortality. Their work is an important contribution to risk-adapted supportive care. This Article Commentary argues, however, that early discharge is not a universally portable intervention. Its safety depends not only on patient biology and initial clinical stability, but also on the surrounding health-care infrastructure: rapid microbiology, timely antibiotics, 24-h oncology consultation, reliable transport, informed caregivers, and guaranteed urgent reassessment. From the perspective of pediatric hematology-oncology practice in Van, eastern Türkiye, the distance from tertiary care, variability in after-hours pediatric oncology expertise, and uneven access to rapid reassessment can make direct adoption of such a pathway nearly impossible without explicit safeguards. The central issue is therefore not whether low-risk patients can ever be discharged early, but which patients, families, centers, and regional systems can do so safely. Future studies and guidelines should define an auditable infrastructure threshold and report implementation outcomes alongside clinical outcomes, so that early-discharge pathways reduce hospitalization without shifting avoidable risk onto families and geographically remote services. This distinction is essential for equitable implementation in real-world oncology practice.